Literature DB >> 22649133

Missing data in clinical studies: issues and methods.

Joseph G Ibrahim1, Haitao Chu, Ming-Hui Chen.   

Abstract

Missing data are a prevailing problem in any type of data analyses. A participant variable is considered missing if the value of the variable (outcome or covariate) for the participant is not observed. In this article, various issues in analyzing studies with missing data are discussed. Particularly, we focus on missing response and/or covariate data for studies with discrete, continuous, or time-to-event end points in which generalized linear models, models for longitudinal data such as generalized linear mixed effects models, or Cox regression models are used. We discuss various classifications of missing data that may arise in a study and demonstrate in several situations that the commonly used method of throwing out all participants with any missing data may lead to incorrect results and conclusions. The methods described are applied to data from an Eastern Cooperative Oncology Group phase II clinical trial of liver cancer and a phase III clinical trial of advanced non-small-cell lung cancer. Although the main area of application discussed here is cancer, the issues and methods we discuss apply to any type of study.

Entities:  

Mesh:

Year:  2012        PMID: 22649133      PMCID: PMC3948388          DOI: 10.1200/JCO.2011.38.7589

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  20 in total

1.  Non-ignorable missing covariates in generalized linear models.

Authors:  S R Lipsitz; J G Ibrahim; M H Chen; H Peterson
Journal:  Stat Med       Date:  1999 Sep 15-30       Impact factor: 2.373

2.  Generalized additive selection models for the analysis of studies with potentially nonignorable missing outcome data.

Authors:  Daniel O Scharfstein; Rafael A Irizarry
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

3.  Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.

Authors:  Stuart G Baker; Garrett M Fitzmaurice; Laurence S Freedman; Barnett S Kramer
Journal:  Biostatistics       Date:  2005-05-27       Impact factor: 5.899

4.  On estimation of vaccine efficacy using validation samples with selection bias.

Authors:  Daniel O Scharfstein; M Elizabeth Halloran; Haitao Chu; Michael J Daniels
Journal:  Biostatistics       Date:  2006-03-23       Impact factor: 5.899

5.  Random Effects Models in a Meta-Analysis of the Accuracy of Two Diagnostic Tests Without a Gold Standard.

Authors:  Haitao Chu; Sining Chen; Thomas A Louis
Journal:  J Am Stat Assoc       Date:  2009-06-01       Impact factor: 5.033

6.  Estimating equations with incomplete categorical covariates in the Cox model.

Authors:  S R Lipsitz; J G Ibrahim
Journal:  Biometrics       Date:  1998-09       Impact factor: 2.571

7.  A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.

Authors:  G Falkson; A Cnaan; I W Simson; Y Dayal; H Falkson; T J Smith; D G Haller
Journal:  Am J Clin Oncol       Date:  1990-12       Impact factor: 2.339

8.  Using the EM-algorithm for survival data with incomplete categorical covariates.

Authors:  S R Lipsitz; J G Ibrahim
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

9.  Parameter estimation from incomplete data in binomial regression when the missing data mechanism is nonignorable.

Authors:  J G Ibrahim; S R Lipsitz
Journal:  Biometrics       Date:  1996-09       Impact factor: 2.571

10.  Hepatocellular carcinoma. An ECOG randomized phase II study of beta-interferon and menogaril.

Authors:  G Falkson; S Lipsitz; E Borden; I Simson; D Haller
Journal:  Am J Clin Oncol       Date:  1995-08       Impact factor: 2.339

View more
  63 in total

1.  Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence.

Authors:  Alexandra J White; Patrick T Bradshaw; Amy H Herring; Susan L Teitelbaum; Jan Beyea; Steven D Stellman; Susan E Steck; Irina Mordukhovich; Sybil M Eng; Lawrence S Engel; Kathleen Conway; Maureen Hatch; Alfred I Neugut; Regina M Santella; Marilie D Gammon
Journal:  Environ Int       Date:  2016-02-13       Impact factor: 9.621

2.  Purposeful variable selection and stratification to impute missing Focused Assessment with Sonography for Trauma data in trauma research.

Authors:  Paul A Fuchs; Deborah J del Junco; Erin E Fox; John B Holcomb; Mohammad H Rahbar; Charles A Wade; Louis H Alarcon; Karen J Brasel; Eileen M Bulger; Mitchell J Cohen; John G Myers; Peter Muskat; Herb A Phelan; Martin A Schreiber; Bryan A Cotton
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

3.  No association between colorectal cancer worry and screening uptake in Appalachian Ohio.

Authors:  Adana A Llanos; Michael L Pennell; Gregory S Young; Cathy M Tatum; Mira L Katz; Electra D Paskett
Journal:  J Public Health (Oxf)       Date:  2014-05-20       Impact factor: 2.341

4.  Examining solutions to missing data in longitudinal nursing research.

Authors:  Mary B Roberts; Mary C Sullivan; Suzy B Winchester
Journal:  J Spec Pediatr Nurs       Date:  2017-04       Impact factor: 1.260

Review 5.  Reporting and handling missing values in clinical studies in intensive care units.

Authors:  Aurélien Vesin; Elie Azoulay; Stéphane Ruckly; Lucile Vignoud; Kateřina Rusinovà; Dominique Benoit; Marcio Soares; Paulo Azeivedo-Maia; Fekri Abroug; Judith Benbenishty; Jean Francois Timsit
Journal:  Intensive Care Med       Date:  2013-05-18       Impact factor: 17.440

Review 6.  Survival analysis in hematologic malignancies: recommendations for clinicians.

Authors:  Julio Delgado; Arturo Pereira; Neus Villamor; Armando López-Guillermo; Ciril Rozman
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

7.  Predictors of vasomotor symptoms among breast cancer survivors.

Authors:  Katherine W Reeves; Michael Pennell; Randi E Foraker; Carolyn J Crandall; Marcia Stefanick; Electra D Paskett
Journal:  J Cancer Surviv       Date:  2018-02-09       Impact factor: 4.442

8.  Network meta-analysis of randomized clinical trials: reporting the proper summaries.

Authors:  Jing Zhang; Bradley P Carlin; James D Neaton; Guoxing G Soon; Lei Nie; Robert Kane; Beth A Virnig; Haitao Chu
Journal:  Clin Trials       Date:  2013-10-03       Impact factor: 2.486

9.  Adherence to Multiple Cancer Screening Tests among Women Living in Appalachia Ohio.

Authors:  Mira L Katz; Paul L Reiter; Gregory S Young; Michael L Pennell; Cathy M Tatum; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

10.  Correlates of colorectal cancer screening among residents of Ohio Appalachia.

Authors:  Electra D Paskett; Adana A Llanos; Gregory S Young; Michael L Pennell; Chul-joo Lee; Mira L Katz
Journal:  J Community Health       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.